
I Review Mattresses for a Living. This Is What I Sleep on at Home
OK, enough shop talk. Here's what I like from testing this mattress. I remember when Nolah first launched the Evolution back in 2020, and it was touted as a good option for side sleepers with all the pressure relief and lumbar support features. When I eventually tried it (and various iterations afterward), it consistently delivered on these marks. Something that has always stood out to me as a major value add was the three firmness options available: plush, luxury firm, and firm. Having a variety of firmnesses is an easy way to make a mattress more accessible to all kinds of sleepers, especially with different body types and sleeping positions.
I landed on 'luxury firm' for a couple of reasons, chief among them being that I'm part of a dynamic sleeping duo. In other words, my husband is a back sleeper, and I'm a stomach sleeper (who is desperately trying to be a side sleeper, mind you). All to say, these sleeping positions can require different firmness levels for adequate support, preferences not even being factored in. Luxury firm is the middle ground, and we've found it to be a welcoming amount of softness that doesn't cancel out the feeling of support.
While I'm on my side, my hips and shoulders get hugged, and if I'm on my stomach, my lower back stays lifted. Everything remains relatively on the same level—hips, lower back, and shoulders—which is what you want for even spine alignment. When on your back, your spine curves away from the bed, but the pillow top takes up that space nicely. That way your back doesn't feel like it's being left out support-wise, and this eliminates a potential cause of back pain.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Apple's blood oxygen monitoring returns to its latest Apple Watches
Apple announced on Thursday it's introducing a redesigned Blood Oxygen feature for some Watch Series 8, Series 10, and Apple Watch Ultra. With this move, Apple is bringing back blood oxygen monitoring by tweaking the feature to get around the International Trade Commission's (ITC) import ban. Blood oxygen data will be measured and calculated on the user's paired iPhone, and results can be viewed in the Respiratory section of the Health app. This means users won't be able to view the data on their Apple Watch, as they'll need to do so on their iPhone. Apple says the update announced today is enabled by a recent U.S. Customs ruling, which means that the tech giant is allowed to import Apple Watches with the redesigned Blood Oxygen feature. The change doesn't affect previously sold models with the original version of the feature or units bought outside the U.S. The redesigned feature only applies to Apple Watches that were sold after the ITC import ban took effect in early 2024. These users can access the redesigned Blood Oxygen feature through an iPhone and Apple Watch software update coming on Thursday. The move comes as Apple has been in an ongoing legal dispute with medical device maker Masimo, which has accused the tech giant of stealing its pulse oximetry technology after initial talks about a potential collaboration. In 2023, Masimo secured a victory against Apple at the ITC to block imports of Apple Watches with blood oxygen monitoring, after the commission found that Apple's technology infringed upon Masimo's patents. Apple then had to remove the feature. Apple counter-sued Masimo, claiming that the company copied Apple Watch features to use in its own smartwatches. The tech giant has also filed an appeal of the ITC ban. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Digital Trends
28 minutes ago
- Digital Trends
Blood oxygen measurement returns to the Apple Watch, sort of
Apple has just announced a software update that will enable the missing blood oxygen level measurement capability on the Apple Watch. The update will enable the biosensing feature on the Watch Series 9, Series 10, and the Apple Watch Ultra 2, once users update their iPhone and smartwatch to the latest build. What does it mean for users? In order to use the blood oxygen feature again on the Apple Watch Series 9, 10, and the Ultra 2, users will have to update their smartwatch to watchOS 11.6.1. The update is now rolling out to users in the United States. In addition to it, the feature will only work when users also update their iPhone to iOS 18.6.1, which has also been released simultaneously. Recommended Videos There's a crucial difference this time around. Instead of seeing the blood oxygen measurement on the Apple Watch screen, users will now have to open the Health app on their iPhone. That's because Apple is now doing the computation on the iPhone, instead of accomplishing it on the wearable and showing the results natively on the Apple Watch due to the patent dispute over alleged theft of the underlying pulse oximetry tech. 'Sensor data from the Blood Oxygen app on Apple Watch will be measured and calculated on the paired iPhone, and results can be viewed in the Respiratory section of the Health app,' instructs Apple. For all other Apple Watch models not affected by the patent dispute, they will continue to measure and show the measurements in the Blood Oxygen app on the smartwatch's screen. Why the hassle? So far, Apple Watch users have been able to track their blood oxygen saturation levels on their Apple Watch and see the readings on their wrists. But owing to a patent dispute with a company named Masimo and an import ban on models that offer this feature, the Cupertino-based company had to pull this capability after lengthy legal battles and an import ban handed down by the International Trade Commission The ban came into effect back in December of 2023, and despite a brief respite, Apple had to disable the blood oxygen features on the watches it sold following the trade restriction in the US. Apple has expressed disagreement with the charges leveled against it by Masimo, after the company filed two seprate lawsuits against the Apple Watch maker. Interestingly, Apple began working on a software-based workaround soon after the ITC ruling. It appears that the company was ready with an alternative route, but it's surprising that Apple took over a year and a half to enable it.


Fox News
29 minutes ago
- Fox News
Mothers speak out after sons killed by nitazene
Grey McCallister and Ruthi Clement join 'Fox & Friends' to discuss losing their sons to the dangerous drug nitazene and issue a warning to other parents.